| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9264830abb1546ae267a47cad928c5bd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4425 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 |
| filingDate |
2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5149599e50033643a7fa9e9320b98e2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2539f55297d8d1a6d29bbd2e58bf865
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d248b985aa28c5cb0552b755e3e2e529 |
| publicationDate |
2006-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006154971-A1 |
| titleOfInvention |
Combination therapies of cicletanine and lacidipine |
| abstract |
Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. More particularly, aspects of the present invention are related to using a combination of cicletanine and lacidipine (a preferred calcium antagonist) for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012006273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008112167-A1 |
| priorityDate |
2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |